Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis.
D000818:Animals; D000917:Antibody Formation; D000941:Antigens / Q000032:analysis; D001327:Autoimmune Diseases; D002464:Cell Migration Inhibition; D003520:Cyclophosphamide / Q000627:therapeutic use; D004195:Disease Models, Animal; D004679:Encephalomyelitis / Q000276:immunology* / Q000517:prevention & control; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D007111:Immunity, Cellular; D007114:Immunization; D007074:Immunoglobulin G / Q000134:cerebrospinal fluid; D008213:Lymphocyte Activation; D008727:Methotrexate / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000209:etiology / Q000276:immunology* / Q000517:prevention & control; D004676:Myelin Basic Protein / Q000627:therapeutic use; D009419:Nerve Tissue Proteins / Q000627:therapeutic use; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D012882:Skin Tests; D014777:Virus Diseases
D000941:Antigens; D007074:Immunoglobulin G; D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins; D003520:Cyclophosphamide; D008727:Methotrexate